Imatinib Mesylate Therapy May Overcome the Poor Prognostic Significance of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia

Blood - United States
doi 10.1182/blood-2004-06-2208
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Imatinib Improves but May Not Fully Reverse the Poor Prognosis of Patients With CML With Derivative Chromosome 9 Deletions

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Cancer Research
Cancer ResearchOncology
2004English

Demonstration of Philadelphia Chromosome Negative Abnormal Clones in Patients With Chronic Myelogenous Leukemia During Major Cytogenetic Responses Induced by Imatinib Mesylate

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Imatinib Mesylate Suppresses Cytokine Synthesis by Activated CD4 T Cells of Patients With Chronic Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Cancer
Cancer ResearchOncology
2008English

Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Blood
BiochemistryImmunologyCell BiologyHematology
2007English

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Increased Cortical Bone Mineralization in Imatinib Treated Patients With Chronic Myelogenous Leukemia

Haematologica
Hematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy